Pharmacological profile of parecoxib: a novel, potent injectable selective cyclooxygenase-2 inhibitor
Authors:
- Naveen K JainNJNaveen K Jain
- Sukhjeet SinghSSSukhjeet Singh
- Shrinivas K KulkarniSKShrinivas K Kulkarni
- 1 April 2004
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 491 (1) , 69-76
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Involvement of peripheral cyclooxygenase-1 and cyclooxygenase-2 in inflammatory painJournal of Pharmacy and Pharmacology, 2002
- Acute studies on safety index of nonsteroidal anti-inflammatory drugs in ratsInflammopharmacology, 2001
- Cyclooxygenase in the vagal afferents: is it involved in the brain prostaglandin response evoked by lipopolysaccharide?Autonomic Neuroscience, 2000
- Up‐regulation of cyclooxygenase‐2 mRNA in the rat spinal cord following peripheral inflammationFEBS Letters, 1996
- Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study1996
- Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissuesFEBS Letters, 1993
- Renal Toxicity of the Nonsteroidal Anti-Inflammatory DrugsAnnual Review of Pharmacology and Toxicology, 1993
- Gastrointestinal Damage Associated with the Use of Nonsteroidal Antiinflammatory DrugsNew England Journal of Medicine, 1992
- Methodological refinements to the mouse paw formalin testJournal of Pharmacological Methods, 1988
- Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbsNeuroscience, 1987